PCGEM1 and metastatic malignant neoplasm in the lymph nodes: PCGEM1 accelerates cell proliferation, invasion and migration by targeting miR-182, while overexpression of PCGEM1 is associated with dismal prognostic outcome, lymph node metastasis and distant metastasis in cervical cancer cases [17].